Literature DB >> 20848159

Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome.

Eraldo de Azevedo Lucio1, Sandro C Gonçalves, Jorge P Ribeiro, Gilberto L Nunes, Jarbas R de Oliveira, Gustavo N Araujo, Marco V Wainstein.   

Abstract

OBJECTIVE: To evaluate the association between plasma myeloperoxidase (MPO) levels and angiographic severity of coronary atherosclerotic lesions in patients with non-ST elevation acute coronary syndrome (ACS). DESIGN AND METHODS: This cross-sectional study examined high-risk ACS patients who underwent coronary angiography within 72 h of the onset of symptoms by measuring their plasma MPO levels after sheath insertion. Gensini score was used to evaluate angiographic severity of coronary artery disease.
RESULTS: A total of 48 patients were included in the study. Median MPO levels and Gensini scores were 6.9 ng/mL (4.4-73.5 ng/mL) and 10 (0-87.5), respectively. Spearman's correlation coefficient did not show a significant association between MPO levels and Gensini scores (r (s) = 0.2; p = 0.177). There was no correlation between MPO and age, hypertension, diabetes, leukocyte count, troponin I, CK-MB ≥ 2 × ULN (upper limit of normal), TIMI risk score ≥ 4 and Gensini score in the multivariate analysis.
CONCLUSION: Our findings indicate that MPO expression is not associated with anatomical severity of coronary lesions in ACS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20848159     DOI: 10.1007/s00011-010-0247-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  36 in total

1.  Myeloperoxidase and plaque vulnerability.

Authors:  Stanley L Hazen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-07       Impact factor: 8.311

2.  Mechanical plaque sealing in patients with acute coronary syndromes: a local solution for a systemic disease involving whole coronary arterial tree?

Authors:  Turgay Celik; Atila Iyisoy; U Cagdas Yuksel
Journal:  Int J Cardiol       Date:  2008-05-21       Impact factor: 4.164

3.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

Review 4.  Myeloperoxidase and cardiovascular disease.

Authors:  Stephen J Nicholls; Stanley L Hazen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-03-24       Impact factor: 8.311

Review 5.  Myeloperoxidase-generated oxidants and atherosclerosis.

Authors:  E A Podrez; H M Abu-Soud; S L Hazen
Journal:  Free Radic Biol Med       Date:  2000-06-15       Impact factor: 7.376

6.  Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome.

Authors:  Erdal Cavusoglu; Cyril Ruwende; Calvin Eng; Vineet Chopra; Sunitha Yanamadala; Luther T Clark; David J Pinsky; Jonathan D Marmur
Journal:  Am J Cardiol       Date:  2007-04-05       Impact factor: 2.778

7.  Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.

Authors:  David A Morrow; Marc S Sabatine; Marie-Luise Brennan; James A de Lemos; Sabina A Murphy; Christian T Ruff; Nader Rifai; Christopher P Cannon; Stanley L Hazen
Journal:  Eur Heart J       Date:  2008-03-12       Impact factor: 29.983

8.  The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCI) is suppressed by anti-rheumatic drugs.

Authors:  F Shabani; J McNeil; L Tippett
Journal:  Free Radic Res       Date:  1998-02

9.  Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.

Authors:  G Ndrepepa; S Braun; J Mehilli; N von Beckerath; A Schömig; A Kastrati
Journal:  Eur J Clin Invest       Date:  2008-02       Impact factor: 4.686

10.  Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction.

Authors:  Britta U Goldmann; Volker Rudolph; Tanja K Rudolph; Ann-Katrin Holle; Matthias Hillebrandt; Thomas Meinertz; Stephan Baldus
Journal:  Free Radic Biol Med       Date:  2009-04-09       Impact factor: 7.376

View more
  2 in total

1.  Cardiovascular epidemiology: the legacy of sound national and international studies.

Authors:  Sandra C Fuchs; Andreia Biolo; Carisi A Polanczyk
Journal:  Arq Bras Cardiol       Date:  2013-08       Impact factor: 2.000

2.  Association between serum myeloperoxidase levels and coronary artery disease in patients without diabetes, hypertension, obesity, and hyperlipidemia.

Authors:  Zahra Hasanpour; Shaghayegh Haghjooy Javanmard; Maryam Gharaaty; Masoumeh Sadeghi
Journal:  Adv Biomed Res       Date:  2016-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.